Orphan Drug Designation Application Process: Common Pitfalls to Avoid
Orphan Drug Designation Application Process: Common Pitfalls to Avoid How to Avoid Common Mistakes in Orphan Drug Designation Applications Understanding the Orphan Drug Designation Process The U.S. Food and Drug Administration (FDA) offers Orphan Drug Designation (ODD) to sponsors developing therapies for rare diseases—conditions affecting fewer than 200,000 people in the United States. This designation…
Read More “Orphan Drug Designation Application Process: Common Pitfalls to Avoid” »